CAM
TIL icon

Cormorant Asset Management’s Instil Bio TIL Stock Holding History

Cormorant Asset Management’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-7,500
Closed -$3.76M – 125
2021
Q1 		$3.76M Buy
+7,500
New +$3.85M 0.08% 100

Other funds holding TIL

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Cormorant Asset Management's TIL Position: Q2 2021 in Review

Cormorant Asset Management sold out of Instil Bio (TIL) in Q2 2021, closing a stake of 7,500 shares — an estimated $3.76M sold.

Cormorant Asset Management first reported a position in TIL in Q1 2021 and held it in 1 quarter. The position peaked at $3.76M in Q1 2021. 62 funds tracked by Wall St. Rank hold TIL as of Q2 2021.

  • Cormorant Asset Management reported no remaining Instil Bio position as of Q2 2021 after selling out during the quarter.
  • Cormorant Asset Management sold 7,500 Instil Bio shares in Q2 2021, an estimated $3.76M.
  • Cormorant Asset Management first reported a position in Instil Bio in Q1 2021 and held it in 1 quarter.
  • Cormorant Asset Management's Instil Bio position peaked at $3.76M in Q1 2021.
  • 62 funds tracked by Wall St. Rank held Instil Bio as of Q2 2021.

Based on Cormorant Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.